Search Theodore F. 4

What Happened

• Theodore F. Search, a director of OS Therapies Inc. (OSTX), was granted options to purchase 50,000 shares of the company's common stock on January 22, 2026. The Form 4 reports the acquisition as a derivative award with a reported price of $0.00 (no cash exchanged at grant). The options vest in full on the one-year anniversary of the grant, provided Search remains a director on that date.

Key Details

• Transaction date: January 22, 2026 (Grant of option award)
• Reported consideration: $0.00 (award/derivative grant)
• Number of options: 50,000 (vest in full on the one-year anniversary if director)
• Shares owned after transaction: not specified on the Form 4
• Footnotes: (F1) Search serves on board of managers of Mill River Partners LLC and shares voting and investment power with respect to these shares; (F2) vesting condition described above
• Filing date: February 13, 2026 — this Form 4 was filed well after the typical two-business-day window and is therefore late

Context

• This was an option grant (a derivative award), not an open-market purchase or sale. No shares were sold or bought immediately; the award simply gives the right to buy shares in the future if vesting conditions are met. Option grants to directors are common compensation and do not, by themselves, imply a near-term bullish or bearish trading signal.